biotech

New Business

Hong Kong biotech start-up eyes global pest control market with scent-based products

For Rick Lui, a decision to take a one-year break from university in 2021 is starting to pay off. A…

Read More »
Tech

Chinese biotech sector is blowing hot as M&A and IPO deals surge amid Covid-19 pandemic

China’s biotechnology merger and acquisition (M&A) transactions have almost doubled this year, with interest perking up among investors amid a…

Read More »
Tech

Baidu, investors said to be in talks to raise US$2 billion for biotech start-up using AI technology

Chinese tech giant Baidu is in talks with investors to raise up to US$2 billion over three years for a…

Read More »
Tech

Yifan Pharma’s unit, eyeing US$5.5 billion post-chemotherapy treatment market dominated by Amgen, considers IPO in 2021

Evive Biotech, a unit of Shenzhen-listed Yifan Pharmaceutical, aims to break the dominance of American drugs developer Amgen in the…

Read More »
Tech

Mergers afoot for China’s biotechnology industry as suppliers become attractive targets for Big Pharma

China’s fragmented outsourced drug discovery services market will see further consolidation as companies seek to grab market share amid a…

Read More »
Tech

Billionaire Li Ka-shing’s biotech unit hopes for new cancer drug approvals, expands sales army in China amid stock rally in London

Hutchison China MediTech (Chi-Med), whose stock has surged 70 per cent in London over the past six months, expects to…

Read More »
Tech

Hong Kong scientist behind artificial ‘mini-hearts’ takes Novoheart closer to China with facilities to quicken drug discovery process

Novoheart Holdings, the inventor of artificial “mini-hearts” co-founded by a Hong Kong scientist, is expanding its research and manufacturing budget…

Read More »
Back to top button